Filter
563
Text search:
laboratory
biosafety
Featured
Recommendations
92
New Publications
138
Language
Document type
No document type
289
Guidelines
128
Studies & Reports
55
Manuals
46
Strategic & Response Plan
24
Training Material
8
Situation Updates
5
Fact sheets
5
Resource Platforms
2
Brochures
1
Countries / Regions
India
33
Sierra Leone
21
Africa
18
Nigeria
17
Western and Central Europe
17
Latin America and the Carribbean
16
Ghana
12
Kenya
12
Rwanda
12
Liberia
11
Eastern Europe
11
Uganda
10
Brazil
10
Global
10
Ethiopia
8
West and Central Africa
8
Zambia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Congo, Democratic Republic of
6
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Nepal
5
South–East Asia Region
5
Russia
5
Guinea
4
Syria
4
Eastern Europe and Central Asia
4
Spain
4
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Namibia
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
202
Pharmacy & Technologies
52
Clinical Guidelines
46
Key Resources
22
Public Health
21
Women & Child Health
5
Capacity Building
1
Toolboxes
COVID-19
123
TB
102
Rapid Response
78
Ebola
60
AMR
37
HIV
14
Zika
11
NTDs
11
Conflict
9
Polio
8
Pharmacy
7
Caregiver
6
Planetary Health
6
Specific Hazards
4
Cholera
3
Natural Hazards
3
Health Financing Toolbox
2
Mental Health
1
Global Health Education
1
The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete action to be taken and where countries will requir
...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10
...
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over
...
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health profes
...
Laboratory Safety Handbook. Global edition
Las pruebas de cultivo y sensibilidad a fármacos son necesarias especialmente para los pacientes con riesgo de tuberculosis resistente a los medicamentos y para vigilar su respuesta al tratamiento. Si b
...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and informati
...
The immediate objective of the country visit to Cameroon was to ensure that the country is as operationally ready as possible to effectively and safely detect, investigate and report potential Ebola virus disease cases and to mount an effective response that will prevent a larger outbreak. After te
...
User manual.
Accessed: 02.05.2020
These consolidated guidelines provide recommendations for comprehensive prevention and case management strategies in Kenya
Scope of the Guidelines: Infection prevention and control Patient triage Emergency Medical Services Case management
...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference
...
The following protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 virus infection has been reported. Each country may need to tailor some aspects of this protocol to align with public health,
...
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with
...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and informati
...
he Framework sets the requirements for facilities handling High Consequence Agents and Toxins (HCATs) and guides the implementation of laboratory biosafety and biosecurity practices associated with
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
Outline
• Welcome and objectives
• Microbiology, epidemiology and clinical presentation
• Surveillance for imported cases including case definitions
• Laboratory diagnosis • Infection prevention and hospital readiness
• Patient
...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatmen
...
